Recent reports highlight the ongoing crisis for Kenvue amidst unproven links between Tylenol and autism, further fueled by President Trump's announcement, while the FDA plans to relabel Leucovorin for potential autism symptom reduction.

• Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis — The New York Times Health -
• Tylenol, Autism and Vaccines: What to Know After Trump’s Announcement — The New York Times Health -
• F.D.A. to Relabel Leucovorin for Autism Treatment — The New York Times Health -

• Trump Announcement Said to Focus on Unproven Link Between Tylenol and Autism — The New York Times Health -

Gene therapies offering cures for rare diseases are facing abandonment by drug companies due to prohibitive production costs, leaving patients without sustained access to treatment.

• These Patients Got the Cure. Then It Went Away. — The New York Times Health -

A maternity ward in Chad is struggling to cope with one of the world's worst humanitarian crises as U.S. aid dwindles, putting pregnant women's lives at risk.

• A Maternity Ward in Chad Reaches Its Breaking Point as U.S. Aid Dries Up — The New York Times Health -

The health community mourns Louise Vincent, a prominent drug user who championed the harm reduction movement, advocating for needle exchanges, naloxone, and safer drug practices.

• Louise Vincent, 49, Drug User Who Led Harm Reduction Movement, Dies — The New York Times Health -

Setting boundaries in relationships is presented as a counterintuitive yet beneficial strategy for improving interpersonal connections through establishing clear rules and limitations.

• What It Means to Set a Boundary — The New York Times Health -